Clinical trial NCT00889616 - References

Malaria — Phase I Study of the Safety and Immunogenicity of BSAM-2/Alhydrogel +CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria in Adults in the US and Mali

Citation(s)

•   Healer J, Crawford S, Ralph S, McFadden G, Cowman AF
  Independent translocation of two micronemal proteins in developing Plasmodium falciparum merozoites. Infect Immun. 2002 Oct;70(10):5751-8.
•   Richie TL, Saul A
  Progress and challenges for malaria vaccines. Nature. 2002 Feb 7;415(6872):694-701. Review.
•   Sachs J, Malaney P
  The economic and social burden of malaria. Nature. 2002 Feb 7;415(6872):680-5. Review.

Phase 1 Study of the Safety and Immunogenicity of BSAM-2/Alhydrogel +CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria in Adults in the US and in Bancoumana, Mali

Details for clinical trial NCT00889616